Global Medicinal Suppositories Market
Global Medicinal Suppositories Market

Medicinal Suppositories Comprehensive Study by Type (Rectal Suppositories, Vaginal Suppositories, Urethral Suppositories), Application (Pediatrics, Geriatrics, Gynecology), Therapeutic Type (Anti-Malarial, Anti-Bacterial, Anti-Fungal, Anti-Biotic, Others), End Use (Hospitals, Clinics, Other) Players and Region - Global Market Outlook to 2026

Medicinal Suppositories Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Sep 2021 Edition 230 Pages 218 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Medicinal Suppositories Market Scope?
A Medical suppository is a solid drug that is inserted into the rectum, urethra, or vaginal canal. The most prevalent variety is rectal suppositories. While other methods of drug delivery, such as the oral route, are unavailable, Medical suppositories are frequently employed; this is especially true when patients are unconscious. A Medical suppository can be oval, circular, or cone-shaped, with gelatin or cocoa butter as a surrounding material.

The Medicinal Suppositories market study is being classified by Type (Rectal Suppositories, Vaginal Suppositories and Urethral Suppositories), by Application (Pediatrics, Geriatrics and Gynecology) and major geographies with country level break-up.

Medical suppositories are in higher demand than ever before. This industry's pharmaceutical companies face numerous hurdles. Unither, Dr. Reddy's Laboratories, Sun Pharma, and Cipla are among the industry's top competitors. Many worldwide and regional service providers participate in the business and compete directly with industry leaders. It has been discovered that market-leading players are substantially spending in technological advancement and resource utilization in order to enhance the Market position. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Medicinal Suppositories market throughout the predicted period.

Meredian Enterprises (India), Bliss GVS Pharma (India), Teva Pharmaceuticals (United States), Priyans Drugs (Singapore), Delpharm (France), Aenova Holding (Germany), Nivagen Pharmaceuticals Inc (United States), Edesa Biotech (Canada), Citius Pharmaceuticals (United States) and FAMAR (Greece) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Irisys (United Kingdom), Roivant Sciences (Switzerland) and Mfine (India).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Medicinal Suppositories market by Type, Application and Region.

On the basis of geography, the market of Medicinal Suppositories has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In April 2021 Teva Pharmaceuticals released a statement about its new product launch in the US market. Casana (mesalamine) suppository drug used to treat people with active ulcerative proctitis with a 1000 mg potency generic form.


Influencing Market Trend
  • Due to Technological Advancement Medical Suppositories are Available in All Weight, Shape, and Size

Market Drivers
  • Glycerol with Water Medication Suppositories are Expected to Account for a Significant Share of the Entire Business throughout the Forecast Period
  • Medical Suppositories with Fatty Bases are Expected to Hold a Sizable Market around the Globe

Opportunities
  • Potential Expansion of Oral Solids and Suppositories
  • Control of Viral Diseases with the Use of Vaginal and Rectal Pharmaceutical Suppositories Has Shown Positive Effects in Vital Antiretroviral Therapies

Restraints
  • Medical Suppositories are Not Suitable for People Who Suffer from Diarrhea
  • Because of the Strict Regulations Guidelines in the Competitive Marketplace, Entry Barriers are Significantly Higher in Competitive Industries than in Semi-Regulated Markets

Challenges
  • The Medication May Leak Out and Cause Negative Effects
  • The Medicine is Not Absorbed as Well as if it were taken by Mouth


Key Target Audience
Venture and Capitalist, Raw Materials Suppliers, Healthcare Research Organizations, Government Hospitals and Research Organization, New Entrants/Investors and End-Use Industries

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Frequently Asked Questions (FAQ):

1. At what growth rate would the Medicinal Suppositories market expands?
The Global Medicinal Suppositories market is expected to see a growth of % during projected year 2020 to 2026.

2. Who are the prominent players of the Global Medicinal Suppositories market?
The prominent players of Global Medicinal Suppositories market are Meredian Enterprises (India), Bliss GVS Pharma (India), Teva Pharmaceuticals (United States), Priyans Drugs (Singapore), Delpharm (France), Aenova Holding (Germany), Nivagen Pharmaceuticals Inc (United States), Edesa Biotech (Canada), Citius Pharmaceuticals (United States) and FAMAR (Greece), to name a few.

3. What are the top priorities to focus for Medicinal Suppositories marketís growth?
In this highly competitive & fast evolving Medicinal Suppositories industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.
Report Objectives / Segmentation Covered
By Type
  • Rectal Suppositories
  • Vaginal Suppositories
  • Urethral Suppositories
By Application
  • Pediatrics
  • Geriatrics
  • Gynecology
By Therapeutic Type
  • Anti-Malarial
  • Anti-Bacterial
  • Anti-Fungal
  • Anti-Biotic
  • Others

By End Use
  • Hospitals
  • Clinics
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Glycerol with Water Medication Suppositories are Expected to Account for a Significant Share of the Entire Business throughout the Forecast Period
      • 3.2.2. Medical Suppositories with Fatty Bases are Expected to Hold a Sizable Market around the Globe
    • 3.3. Market Challenges
      • 3.3.1. The Medication May Leak Out and Cause Negative Effects
      • 3.3.2. The Medicine is Not Absorbed as Well as if it were taken by Mouth
    • 3.4. Market Trends
      • 3.4.1. Due to Technological Advancement Medical Suppositories are Available in All Weight, Shape, and Size
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Medicinal Suppositories, by Type, Application, Therapeutic Type, End Use and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Medicinal Suppositories (Value)
      • 5.2.1. Global Medicinal Suppositories by: Type (Value)
        • 5.2.1.1. Rectal Suppositories
        • 5.2.1.2. Vaginal Suppositories
        • 5.2.1.3. Urethral Suppositories
      • 5.2.2. Global Medicinal Suppositories by: Application (Value)
        • 5.2.2.1. Pediatrics
        • 5.2.2.2. Geriatrics
        • 5.2.2.3. Gynecology
      • 5.2.3. Global Medicinal Suppositories by: Therapeutic Type (Value)
        • 5.2.3.1. Anti-Malarial
        • 5.2.3.2. Anti-Bacterial
        • 5.2.3.3. Anti-Fungal
        • 5.2.3.4. Anti-Biotic
        • 5.2.3.5. Others
      • 5.2.4. Global Medicinal Suppositories by: End Use (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Clinics
        • 5.2.4.3. Other
      • 5.2.5. Global Medicinal Suppositories Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Medicinal Suppositories (Price)
      • 5.3.1. Global Medicinal Suppositories by: Type (Price)
  • 6. Medicinal Suppositories: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Meredian Enterprises (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bliss GVS Pharma (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teva Pharmaceuticals (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Priyans Drugs (Singapore)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Delpharm (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Aenova Holding (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nivagen Pharmaceuticals Inc (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Edesa Biotech (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Citius Pharmaceuticals (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. FAMAR (Greece)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Medicinal Suppositories Sale, by Type, Application, Therapeutic Type, End Use and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Medicinal Suppositories (Value)
      • 7.2.1. Global Medicinal Suppositories by: Type (Value)
        • 7.2.1.1. Rectal Suppositories
        • 7.2.1.2. Vaginal Suppositories
        • 7.2.1.3. Urethral Suppositories
      • 7.2.2. Global Medicinal Suppositories by: Application (Value)
        • 7.2.2.1. Pediatrics
        • 7.2.2.2. Geriatrics
        • 7.2.2.3. Gynecology
      • 7.2.3. Global Medicinal Suppositories by: Therapeutic Type (Value)
        • 7.2.3.1. Anti-Malarial
        • 7.2.3.2. Anti-Bacterial
        • 7.2.3.3. Anti-Fungal
        • 7.2.3.4. Anti-Biotic
        • 7.2.3.5. Others
      • 7.2.4. Global Medicinal Suppositories by: End Use (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Clinics
        • 7.2.4.3. Other
      • 7.2.5. Global Medicinal Suppositories Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Medicinal Suppositories (Price)
      • 7.3.1. Global Medicinal Suppositories by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Medicinal Suppositories: by Type(USD Million)
  • Table 2. Medicinal Suppositories Rectal Suppositories , by Region USD Million (2015-2020)
  • Table 3. Medicinal Suppositories Vaginal Suppositories , by Region USD Million (2015-2020)
  • Table 4. Medicinal Suppositories Urethral Suppositories , by Region USD Million (2015-2020)
  • Table 5. Medicinal Suppositories: by Application(USD Million)
  • Table 6. Medicinal Suppositories Pediatrics , by Region USD Million (2015-2020)
  • Table 7. Medicinal Suppositories Geriatrics , by Region USD Million (2015-2020)
  • Table 8. Medicinal Suppositories Gynecology , by Region USD Million (2015-2020)
  • Table 9. Medicinal Suppositories: by Therapeutic Type(USD Million)
  • Table 10. Medicinal Suppositories Anti-Malarial , by Region USD Million (2015-2020)
  • Table 11. Medicinal Suppositories Anti-Bacterial , by Region USD Million (2015-2020)
  • Table 12. Medicinal Suppositories Anti-Fungal , by Region USD Million (2015-2020)
  • Table 13. Medicinal Suppositories Anti-Biotic , by Region USD Million (2015-2020)
  • Table 14. Medicinal Suppositories Others , by Region USD Million (2015-2020)
  • Table 15. Medicinal Suppositories: by End Use(USD Million)
  • Table 16. Medicinal Suppositories Hospitals , by Region USD Million (2015-2020)
  • Table 17. Medicinal Suppositories Clinics , by Region USD Million (2015-2020)
  • Table 18. Medicinal Suppositories Other , by Region USD Million (2015-2020)
  • Table 19. South America Medicinal Suppositories, by Country USD Million (2015-2020)
  • Table 20. South America Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 21. South America Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 22. South America Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 23. South America Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 24. Brazil Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 25. Brazil Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 26. Brazil Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 27. Brazil Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 28. Argentina Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 29. Argentina Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 30. Argentina Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 31. Argentina Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 32. Rest of South America Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 33. Rest of South America Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 34. Rest of South America Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 35. Rest of South America Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 36. Asia Pacific Medicinal Suppositories, by Country USD Million (2015-2020)
  • Table 37. Asia Pacific Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 38. Asia Pacific Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 39. Asia Pacific Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 40. Asia Pacific Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 41. China Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 42. China Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 43. China Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 44. China Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 45. Japan Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 46. Japan Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 47. Japan Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 48. Japan Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 49. India Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 50. India Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 51. India Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 52. India Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 53. South Korea Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 54. South Korea Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 55. South Korea Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 56. South Korea Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 57. Taiwan Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 58. Taiwan Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 59. Taiwan Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 60. Taiwan Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 61. Australia Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 62. Australia Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 63. Australia Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 64. Australia Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 69. Europe Medicinal Suppositories, by Country USD Million (2015-2020)
  • Table 70. Europe Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 71. Europe Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 72. Europe Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 73. Europe Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 74. Germany Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 75. Germany Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 76. Germany Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 77. Germany Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 78. France Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 79. France Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 80. France Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 81. France Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 82. Italy Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 83. Italy Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 84. Italy Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 85. Italy Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 86. United Kingdom Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 87. United Kingdom Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 88. United Kingdom Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 89. United Kingdom Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 90. Netherlands Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 91. Netherlands Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 92. Netherlands Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 93. Netherlands Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 94. Rest of Europe Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 95. Rest of Europe Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 96. Rest of Europe Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 97. Rest of Europe Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 98. MEA Medicinal Suppositories, by Country USD Million (2015-2020)
  • Table 99. MEA Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 100. MEA Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 101. MEA Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 102. MEA Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 103. Middle East Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 104. Middle East Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 105. Middle East Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 106. Middle East Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 107. Africa Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 108. Africa Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 109. Africa Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 110. Africa Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 111. North America Medicinal Suppositories, by Country USD Million (2015-2020)
  • Table 112. North America Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 113. North America Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 114. North America Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 115. North America Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 116. United States Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 117. United States Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 118. United States Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 119. United States Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 120. Canada Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 121. Canada Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 122. Canada Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 123. Canada Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 124. Mexico Medicinal Suppositories, by Type USD Million (2015-2020)
  • Table 125. Mexico Medicinal Suppositories, by Application USD Million (2015-2020)
  • Table 126. Mexico Medicinal Suppositories, by Therapeutic Type USD Million (2015-2020)
  • Table 127. Mexico Medicinal Suppositories, by End Use USD Million (2015-2020)
  • Table 128. Medicinal Suppositories: by Type(USD/Units)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Medicinal Suppositories: by Type(USD Million)
  • Table 140. Medicinal Suppositories Rectal Suppositories , by Region USD Million (2021-2026)
  • Table 141. Medicinal Suppositories Vaginal Suppositories , by Region USD Million (2021-2026)
  • Table 142. Medicinal Suppositories Urethral Suppositories , by Region USD Million (2021-2026)
  • Table 143. Medicinal Suppositories: by Application(USD Million)
  • Table 144. Medicinal Suppositories Pediatrics , by Region USD Million (2021-2026)
  • Table 145. Medicinal Suppositories Geriatrics , by Region USD Million (2021-2026)
  • Table 146. Medicinal Suppositories Gynecology , by Region USD Million (2021-2026)
  • Table 147. Medicinal Suppositories: by Therapeutic Type(USD Million)
  • Table 148. Medicinal Suppositories Anti-Malarial , by Region USD Million (2021-2026)
  • Table 149. Medicinal Suppositories Anti-Bacterial , by Region USD Million (2021-2026)
  • Table 150. Medicinal Suppositories Anti-Fungal , by Region USD Million (2021-2026)
  • Table 151. Medicinal Suppositories Anti-Biotic , by Region USD Million (2021-2026)
  • Table 152. Medicinal Suppositories Others , by Region USD Million (2021-2026)
  • Table 153. Medicinal Suppositories: by End Use(USD Million)
  • Table 154. Medicinal Suppositories Hospitals , by Region USD Million (2021-2026)
  • Table 155. Medicinal Suppositories Clinics , by Region USD Million (2021-2026)
  • Table 156. Medicinal Suppositories Other , by Region USD Million (2021-2026)
  • Table 157. South America Medicinal Suppositories, by Country USD Million (2021-2026)
  • Table 158. South America Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 159. South America Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 160. South America Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 161. South America Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 162. Brazil Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 163. Brazil Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 164. Brazil Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 165. Brazil Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 166. Argentina Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 167. Argentina Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 168. Argentina Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 169. Argentina Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 170. Rest of South America Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 171. Rest of South America Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 172. Rest of South America Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 173. Rest of South America Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 174. Asia Pacific Medicinal Suppositories, by Country USD Million (2021-2026)
  • Table 175. Asia Pacific Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 176. Asia Pacific Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 177. Asia Pacific Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 178. Asia Pacific Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 179. China Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 180. China Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 181. China Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 182. China Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 183. Japan Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 184. Japan Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 185. Japan Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 186. Japan Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 187. India Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 188. India Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 189. India Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 190. India Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 191. South Korea Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 192. South Korea Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 193. South Korea Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 194. South Korea Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 195. Taiwan Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 196. Taiwan Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 197. Taiwan Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 198. Taiwan Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 199. Australia Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 200. Australia Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 201. Australia Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 202. Australia Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 203. Rest of Asia-Pacific Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 204. Rest of Asia-Pacific Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 205. Rest of Asia-Pacific Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 206. Rest of Asia-Pacific Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 207. Europe Medicinal Suppositories, by Country USD Million (2021-2026)
  • Table 208. Europe Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 209. Europe Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 210. Europe Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 211. Europe Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 212. Germany Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 213. Germany Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 214. Germany Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 215. Germany Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 216. France Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 217. France Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 218. France Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 219. France Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 220. Italy Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 221. Italy Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 222. Italy Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 223. Italy Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 224. United Kingdom Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 225. United Kingdom Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 226. United Kingdom Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 227. United Kingdom Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 228. Netherlands Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 229. Netherlands Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 230. Netherlands Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 231. Netherlands Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 232. Rest of Europe Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 233. Rest of Europe Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 234. Rest of Europe Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 235. Rest of Europe Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 236. MEA Medicinal Suppositories, by Country USD Million (2021-2026)
  • Table 237. MEA Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 238. MEA Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 239. MEA Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 240. MEA Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 241. Middle East Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 242. Middle East Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 243. Middle East Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 244. Middle East Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 245. Africa Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 246. Africa Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 247. Africa Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 248. Africa Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 249. North America Medicinal Suppositories, by Country USD Million (2021-2026)
  • Table 250. North America Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 251. North America Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 252. North America Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 253. North America Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 254. United States Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 255. United States Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 256. United States Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 257. United States Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 258. Canada Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 259. Canada Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 260. Canada Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 261. Canada Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 262. Mexico Medicinal Suppositories, by Type USD Million (2021-2026)
  • Table 263. Mexico Medicinal Suppositories, by Application USD Million (2021-2026)
  • Table 264. Mexico Medicinal Suppositories, by Therapeutic Type USD Million (2021-2026)
  • Table 265. Mexico Medicinal Suppositories, by End Use USD Million (2021-2026)
  • Table 266. Medicinal Suppositories: by Type(USD/Units)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Medicinal Suppositories: by Type USD Million (2015-2020)
  • Figure 5. Global Medicinal Suppositories: by Application USD Million (2015-2020)
  • Figure 6. Global Medicinal Suppositories: by Therapeutic Type USD Million (2015-2020)
  • Figure 7. Global Medicinal Suppositories: by End Use USD Million (2015-2020)
  • Figure 8. South America Medicinal Suppositories Share (%), by Country
  • Figure 9. Asia Pacific Medicinal Suppositories Share (%), by Country
  • Figure 10. Europe Medicinal Suppositories Share (%), by Country
  • Figure 11. MEA Medicinal Suppositories Share (%), by Country
  • Figure 12. North America Medicinal Suppositories Share (%), by Country
  • Figure 13. Global Medicinal Suppositories: by Type USD/Units (2015-2020)
  • Figure 14. Global Medicinal Suppositories share by Players 2020 (%)
  • Figure 15. Global Medicinal Suppositories share by Players (Top 3) 2020(%)
  • Figure 16. Global Medicinal Suppositories share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Meredian Enterprises (India) Revenue, Net Income and Gross profit
  • Figure 19. Meredian Enterprises (India) Revenue: by Geography 2020
  • Figure 20. Bliss GVS Pharma (India) Revenue, Net Income and Gross profit
  • Figure 21. Bliss GVS Pharma (India) Revenue: by Geography 2020
  • Figure 22. Teva Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 23. Teva Pharmaceuticals (United States) Revenue: by Geography 2020
  • Figure 24. Priyans Drugs (Singapore) Revenue, Net Income and Gross profit
  • Figure 25. Priyans Drugs (Singapore) Revenue: by Geography 2020
  • Figure 26. Delpharm (France) Revenue, Net Income and Gross profit
  • Figure 27. Delpharm (France) Revenue: by Geography 2020
  • Figure 28. Aenova Holding (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Aenova Holding (Germany) Revenue: by Geography 2020
  • Figure 30. Nivagen Pharmaceuticals Inc (United States) Revenue, Net Income and Gross profit
  • Figure 31. Nivagen Pharmaceuticals Inc (United States) Revenue: by Geography 2020
  • Figure 32. Edesa Biotech (Canada) Revenue, Net Income and Gross profit
  • Figure 33. Edesa Biotech (Canada) Revenue: by Geography 2020
  • Figure 34. Citius Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 35. Citius Pharmaceuticals (United States) Revenue: by Geography 2020
  • Figure 36. FAMAR (Greece) Revenue, Net Income and Gross profit
  • Figure 37. FAMAR (Greece) Revenue: by Geography 2020
  • Figure 38. Global Medicinal Suppositories: by Type USD Million (2021-2026)
  • Figure 39. Global Medicinal Suppositories: by Application USD Million (2021-2026)
  • Figure 40. Global Medicinal Suppositories: by Therapeutic Type USD Million (2021-2026)
  • Figure 41. Global Medicinal Suppositories: by End Use USD Million (2021-2026)
  • Figure 42. South America Medicinal Suppositories Share (%), by Country
  • Figure 43. Asia Pacific Medicinal Suppositories Share (%), by Country
  • Figure 44. Europe Medicinal Suppositories Share (%), by Country
  • Figure 45. MEA Medicinal Suppositories Share (%), by Country
  • Figure 46. North America Medicinal Suppositories Share (%), by Country
  • Figure 47. Global Medicinal Suppositories: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Meredian Enterprises (India)
  • Bliss GVS Pharma (India)
  • Teva Pharmaceuticals (United States)
  • Priyans Drugs (Singapore)
  • Delpharm (France)
  • Aenova Holding (Germany)
  • Nivagen Pharmaceuticals Inc (United States)
  • Edesa Biotech (Canada)
  • Citius Pharmaceuticals (United States)
  • FAMAR (Greece)
Additional players considered in the study are as follows:
Irisys (United Kingdom) , Roivant Sciences (Switzerland) , Mfine (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation